CANCER CHEMOTHERAPY ACENAPHTHENE ... - Cancer Research

Downloaded from cancerres.aacrjournals.org on August 30, 2013. © 1956 American Association for Cancer
Research.
33
CARBAMATE,
ETHYL —¿ THERAPY
(Continued)
511 v
Hrubisko. II., K TERAPJI
KAZUISTICKYM SDELENIH
LEUKOZ URETANOM S
DVOCH PRIPADOV PAN-
MYELOPATIE PO URETANE. [TREATMENT OF LEU
KEMIA WITH URETHANE WITH TWO CASE HISTORIES
OF PANMYELOPHTHISIS CAUSED BY URETHANE.]
Bratisl. lek. listy, 1948, 28: 401-407.
tab. 12 refs. Complete remissions
achieved in 6 patients with chronic
were
myeloid
leukemia treated with 86 g urethane
over a period of 22 days. In 2 cases of
chronic myeloid leukemia a complication
of panmyelophthisis was caused by the ure
thane treatment. Urethane therapy was un
satisfactory in acute and lymphatic leu
kemia cases.
512
Hrubiïko, M. PRÕSPEVOK K UCINKU URETANU U
LEUKOZ.
Bratisl.
[ACTION OF URETHANE IN LEUKEMIA.]
lek. listy, 1948, 28: 554-561.
8 refs. Urethane in doses up to 80 g ad
ministered to three patients with chronic
myeloid leukemia inhibited leucocyte mito
sis, increased the "ripe" and decreased the
"unripe" leucocyte count of the bone mar
ro*. Urethane showed no changes on the
blood picture of patients with acute leu
kemia.
513
Huggins, C., Yu, S. T. and Jones, R., Jr. IN
HIBITORY EFFECTS OF ETHYL CARBAMATE
STATIC CANCER. Science, 1947, 106:
ON PRO-
147-148.
12 refs.
514 -v
Hule, V. LECBA POLYCYTHAEMIA VERA URETANEM.
[THERAPY OF
Lek. listy,
POLYCYTHEMIA VERA WITH URETHANE.]
Brno, 1949, 4: 283-286. Polycythemia
vera in two males, age 52 and 55 and
one female, age 51 was treated with urethane
in doses from 32.5 rag. to 84 mg. Two re
missions occurred within three months; the
longest remission lasted for seven months.
The number of erythrocytes in these periods
was lowered from 8.7-9.9 million to 6.8-
5.4 million.
515
Hule, V.„URETAN, JEHO ÚÕINEKBIOLOGICKY A
LECEBNY. [URETHANE AND ITS BIOLOGIC AND
THERAPEUTIC EFFECT].
1949, 4: 412-414. A
Lek. listy, Brno,
historical review of
urethane from the time it was first syn
thesized in 1834 through 1949, with a
report of its use in cases of polycythemia
vera.
516
Jadassohn, W. MYCOSIS FONGOÕDE TRAITÉ ÀL'URÉ-
THANE. [URETHANE TREATMENT IN MYCOSIS FUN-
GOIDES.] Dermatologica, Basel, 1948, 96:
274.
517 Jamr.a, M. A. and Mendes, F. T. ANÄLISE HEMATO-
LOGICA E CLÕNICA DO TRATAMENTO DE DEZ CASOS
DE LEUCEMIA PELA URETANA. [HEMATOLOGIC AND
CLINICAL FINDINGS IN THE URETHANE TREATMENT
OF TEN CASES OF LEUKEMIA.] Rev. Hosp. clin.,
S. Paulo, 1948, 3: 23-42. 10 refs.
518 Janele. J. PRISPEVEK K POKUSUM 0 LECENI CHRO-
NICKYCH MYELOS. [ON THE TREATMENT OF CHRONIC
MYELOSIS.] Pediat. listy, Praha, 1947, 2:
261-266. 8 refs. Treatment with urethane,
antireticular cytotoxic serum and x-rays of
chronic myelosis in a five year old boy is
discussed. Besides the palliative results
of the urethane and ACS, the general outcome
of the treatment was unsatisfactory.
519
Karnofsky, D. A. THE MANAGEMENT OF LEUKEMIA
IN ADULTS. N. York State J. M., 1954, 54:
3225-3228. 9 refs. A review.
520
Katz. S. CYTOSTATISCHE STOFFE IN DER BEHANDLUNG
DEA LEUKÄMIE. [CYTOSTATIC SUBSTANCES IN THE
TREATMENT OF LEUKEMIA.] 28 1. München, 1954.
(Inaug. T>¡ss.,München). 42 refs. A re
view of the action of urethane, nitrogen mus
tard and aminopterin.
521
Kelemen, E., BenkB, A. and Tényi, M. P-AMINO-
BENZOESXURE-URETHAN-INTERFERENZ BEI MENSCH
LICHEN LEUKÄMIEN. [P-AMINOBENZOIC ACID-
URETHANE INTERFERENCE IN HUMAN LEUKEMIAS] .
Experientia, Basel, 1949, 5: 77-78. 2 refs.
522
Kennedy, B. J., Nathanson, I. T. and Aub, J. C.
ETHYL CARBAMATE (URETHANE) IN THE TREATMENT
OF MYCOSIS
3_: 66-73.
FUNGOIDES. Cancer
2 pi. 19 refs.
N. Y., 1950,
523 Kjerulf-Jensen, K. URETANBEHANDLINGEN AF LEU-
CAEMI. [TREATMENT OF LEUKEMIA WITH URETHANE.]
Ugeskr. laeger, 1947, 109: 85-87. 5 refs.
524
Koch, F. ÃœEBERAETHYL-URETHANBEHANDLUNG DER
MYCOSIS FUNGOIDES. [URETHANE TREATMENT OF
MYCOSIS FUNGOIDES.] Derm. Wschr., 1947-
1948, 119: 713-715.
525
Kolár, V. O LÉOENÕLEUKAEMIÕ. [TREATMENT OF
LEUKEMIA]. Lek. listy, 19eO, 5: 48-51.
Urethane and nitrogen mustard were administer
ed in conjunction with x-ray therapy to
57 patients with chronic leukemia. The
results of irradiation are considered su
perior to those of urethane and nitrogen
mustard.
526
Krause, P. URETHANBEHANDLUNG EINER CHRONISCHEN
LYMPHADENOSE DER HAUT. [URETHANE THERAPY OF
CHRONIC
Wschr.,
LYMPHADENOSIS OF THE
1950, 121; 105-107.
SKIN.]
A total
Derm
dose'of
130 g urethane caused essential normalization
of blood picture and regression of skin lesions.
527
KÜnzer, W. URETHANWIRKUNGBEI DER "INFEKTIÖSEN
RETICULOENDOTHEHOSE" (ABT-LETTERER-SIWESCHE
KRANKHEIT) . [THE EFFECT OF URETHANE ON THE
"INFECTIOUS RETICULOENDOTHELIOSIS" (ABT-
LETTERER-SIWE DISEASE).] Klin. Wschr., 1948,
26: 694-695. 4 refs.
528
Lambet. TRAITEMENT DES LEUCÉMIES PAR L'URETHANE.
[URETHANE TREATMENT OF LEUKEMIA.] Praxis, Bern,
chroni5~~and 1948, 37: 457. 13 ofSummary acute report leukemia. of 17 cases of
529
Lambin. P. and Masure, R. LE TRAITEMENT DES
LEUCEMIES PAR L'URETHANE. [URETHANE TREAT
MENT OF LEUKEMIA.] Schweiz, ned. Wschr.,
1948, 78: 929-931. 15 refs. Results in
31 cases" of leukemia.
530
Landoli, R. F. ZUR BEHANDLUNG DER AKUTEN LEU
KÄMIEN IM KINDERSALTER MIT URETHAN. [URETHANE
TREATMENT OF ACUTE LEUKEMIAS IN CHILDREN.]
Helvet. paediat. acta., 1948, 3: 232-251.
15 refs.
531
Languillon, J. LE TRAITEMENT DE LA LEUCÉMIE
MYELOIDE PAR L'URETHANE; (X PROPOS D'UN CAS
PERSONNEL). [TREATMENT OF MYELOID LEUKEMIA
WITH URETHANE; ONE PERSONAL CASE.] Med.
trop., 1950, 10: 846-850.